CH LAB-Order (R4)
3.0.0-ci-build - ci-build
CH LAB-Order (R4), published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 3.0.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-lab-order/ and changes regularly. See the Directory of published versions
Official URL: http://fhir.ch/ig/ch-lab-order/ValueSet/ch-lab-order-study-types | Version: 3.0.0-ci-build | |||
Active as of 2024-11-07 | Computable Name: ChLabOrderLabStudyTypes | |||
Copyright/Legal: CC0-1.0 |
refers to https://wiki.ihe.net/index.php/1.3.6.1.4.1.19376.1.3.3.2.1, but without some errors
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Generated Narrative: ValueSet ch-lab-order-study-types
http://loinc.org
Code | Display |
18716-1 | Allergy studies (set) |
18717-9 | Blood bank studies (set) |
18718-7 | Cell marker studies (set) |
18719-5 | Chemistry studies (set) |
18720-3 | Coagulation studies (set) |
18721-1 | Therapeutic drug monitoring studies (set) |
18722-9 | Fertility studies (set) |
18723-7 | Hematology studies (set) |
18724-5 | HLA studies (set) |
18725-2 | Microbiology studies (set) |
18727-8 | Serology studies (set) |
18728-6 | Toxicology studies (set) |
18729-4 | Urinanalysis studies (set) |
18767-4 | Blood gas studies (set) |
18768-2 | Cell counts+Differential studies (set) |
18769-0 | Microbial susceptibility tests Set |
26435-8 | Molecular pathology studies (set) |
26437-4 | Chemistry challenge studies (set) |
26438-2 | Cytology studies (set) |
27898-6 | Pathology studies (set) |
Generated Narrative: ValueSet
Expansion based on Loinc v2.78
This value set contains 20 concepts
Code | System | Display |
18716-1 | http://loinc.org | Allergy studies (set) |
18717-9 | http://loinc.org | Blood bank studies (set) |
18718-7 | http://loinc.org | Cell marker studies (set) |
18719-5 | http://loinc.org | Chemistry studies (set) |
18720-3 | http://loinc.org | Coagulation studies (set) |
18721-1 | http://loinc.org | Therapeutic drug monitoring studies (set) |
18722-9 | http://loinc.org | Fertility studies (set) |
18723-7 | http://loinc.org | Hematology studies (set) |
18724-5 | http://loinc.org | HLA studies (set) |
18725-2 | http://loinc.org | Microbiology studies (set) |
18727-8 | http://loinc.org | Serology studies (set) |
18728-6 | http://loinc.org | Toxicology studies (set) |
18729-4 | http://loinc.org | Urinalysis studies (set) |
18767-4 | http://loinc.org | Blood gas studies (set) |
18768-2 | http://loinc.org | Cell counts+Differential studies (set) |
18769-0 | http://loinc.org | Microbial susceptibility tests Set |
26435-8 | http://loinc.org | Molecular pathology studies (set) |
26437-4 | http://loinc.org | Chemistry challenge studies (set) |
26438-2 | http://loinc.org | Cytology studies (set) |
27898-6 | http://loinc.org | Pathology studies (set) |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |